Cargando…

A Respiratory Syncytial Virus Vaccine Based on the Small Hydrophobic Protein Ectodomain Presented With a Novel Lipid-Based Formulation Is Highly Immunogenic and Safe in Adults: A First-in-Humans Study

BACKGROUND: Respiratory syncytial virus infection can cause lower respiratory tract infection in older adults comparable to influenza, but no vaccines are available. METHODS: This was a randomized, observer-blinded, first-in-humans study of a novel synthetic RSV antigen based on the ectodomain of th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Langley, Joanne M, MacDonald, Lisa D, Weir, Genevieve M, MacKinnon-Cameron, Donna, Ye, Lingyun, McNeil, Shelly, Schepens, Bert, Saelens, Xavier, Stanford, Marianne M, Halperin, Scott A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Major Articles and Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6049039/ https://www.ncbi.nlm.nih.gov/pubmed/29617814 http://dx.doi.org/10.1093/infdis/jiy177

Ejemplares similares

Evaluation of the protective potential of antibody and T cell responses elicited by a novel preventative vaccine towards respiratory syncytial virus small hydrophobic protein
por: Torrey, Heather L., et al.
Publicado: (2020)

A Randomized, Controlled, Observer-Blinded Phase 1 Study of the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine With or Without Alum Adjuvant
por: Langley, Joanne M., et al.
Publicado: (2017)

Leveraging Influenza Virus Surveillance From 2012 to 2015 to Characterize the Burden of Respiratory Syncytial Virus Disease in Canadian Adults ≥50 Years of Age Hospitalized With Acute Respiratory Illness
por: ElSherif, May, et al.
Publicado: (2023)

Knowledge, attitudes, beliefs, and behaviors of pregnant women approached to participate in a Tdap maternal immunization randomized, controlled trial
por: MacDougall, Donna M., et al.
Publicado: (2016)

Respiratory syncytial virus nonstructural proteins 1 and 2: Exceptional disrupters of innate immune responses
por: Sedeyn, Koen, et al.
Publicado: (2019)

Protection and mechanism of action of a novel human respiratory syncytial virus vaccine candidate based on the extracellular domain of small hydrophobic protein
por: Schepens, Bert, et al.
Publicado: (2014)

The challenge of vaccinating adults: attitudes and beliefs of the Canadian public and healthcare providers
por: MacDougall, D M, et al.
Publicado: (2015)

A GFP Expressing Influenza A Virus to Report In Vivo Tropism and Protection by a Matrix Protein 2 Ectodomain-Specific Monoclonal Antibody
por: De Baets, Sarah, et al.
Publicado: (2015)

Randomized Trial of 2 Schedules of Meningococcal B Vaccine in Adolescents and Young Adults, Canada
por: Langley, Joanne M., et al.
Publicado: (2020)

2744. A Phase I Randomized, Observer-Blind, Controlled, Dose Escalation Trial of the Safety and Tolerability of a Single Intramuscular Dose of a PAL Adjuvant (Laboratory Code, FB-631) Co-administered with Seasonal TIV (2013–2014) to Healthy Adults ≥18–50 Years of Age
por: Langley, Joanne Marie, et al.
Publicado: (2019)

Safety and Immunogenicity of an Investigational Respiratory Syncytial Virus Vaccine (RSVPreF3) in Mothers and Their Infants: A Phase 2 Randomized Trial
por: Bebia, Zourab, et al.
Publicado: (2023)

The Role of Matrix Protein 2 Ectodomain in the Development of Universal Influenza Vaccines
por: Saelens, Xavier
Publicado: (2019)

Reduced protection of RIPK3-deficient mice against influenza by matrix protein 2 ectodomain targeted active and passive vaccination strategies
por: Oltean, Teodora, et al.
Publicado: (2022)

Safety and Immunogenicity of a ChAd155-Vectored Respiratory Syncytial Virus (RSV) Vaccine in Healthy RSV-Seropositive Children 12–23 Months of Age
por: Díez-Domingo, Javier, et al.
Publicado: (2022)

A Randomized Controlled Study to Evaluate the Safety and Reactogenicity of a Novel rVLP-Based Plant Virus Nanoparticle Adjuvant Combined with Seasonal Trivalent Influenza Vaccine Following Single Immunization in Healthy Adults 18–50 Years of Age
por: Langley, Joanne, et al.
Publicado: (2020)

IgG3 Snitcher of RSV Infections in the Very Young
por: Schepens, Bert, et al.
Publicado: (2017)

Type III hypersensitivity reactions to a B cell epitope antigen are abrogated using a depot forming vaccine platform
por: MacDonald, Lisa D., et al.
Publicado: (2017)

Healthcare provider awareness, attitudes, beliefs, and behaviors regarding the role of pharmacists as immunizers
por: Di Castri, Antonia M., et al.
Publicado: (2022)

Respiratory Syncytial Virus Incidence and Severity in a Community-Based Prospective Cohort of Children Aged 0–14 Years
por: Smith, Matthew, et al.
Publicado: (2022)

Pneumococcal Conjugate Vaccines Are Protective Against Respiratory Syncytial Virus Hospitalizations in Infants: A Population-Based Observational Study
por: Le, Huong, et al.
Publicado: (2023)

Recurrent Respiratory Syncytial Virus Infection in a CD14-Deficient Patient
por: Besteman, Sjanna B, et al.
Publicado: (2022)

Transmission of Respiratory Syncytial Virus Infection Within Families
por: Heikkinen, Terho, et al.
Publicado: (2014)

Factors Predicting Secondary Respiratory Morbidity Following Early-Life Respiratory Syncytial Virus Infections: Population-Based Cohort Study
por: Sarna, Mohinder, et al.
Publicado: (2023)

Structure-based membrane dome mechanism for Piezo mechanosensitivity
por: Guo, Yusong R, et al.
Publicado: (2017)

Immunogenicity and Safety of an Inactivated Quadrivalent Influenza Vaccine Candidate: A Phase III Randomized Controlled Trial in Children
por: Langley, Joanne M., et al.
Publicado: (2013)

Protective Efficacy of Recombinant Influenza Hemagglutinin Ectodomain Fusions
por: Mittal, Nidhi, et al.
Publicado: (2021)

An Unexpected Encounter: Respiratory Syncytial Virus Nonstructural Protein 1 Interacts with Mediator Subunit MED25
por: Van Royen, Tessa, et al.
Publicado: (2022)

Epidemiology and Characteristics of Respiratory Syncytial Virus Pneumonia in Critically Ill Adults
por: Kim, Taeeun, et al.
Publicado: (2023)

Incidence of Respiratory Syncytial Virus Lower Respiratory Tract Infections During the First 2 Years of Life: A Prospective Study Across Diverse Global Settings( )
por: Langley, Joanne M, et al.
Publicado: (2022)

Maternal Envelope gp41 Ectodomain-Specific Antibodies Are Associated With Increased Mother-to-Child Transmission of Human Immunodeficiency Virus-1
por: Naiman, Nicole E, et al.
Publicado: (2020)

Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F (RSVPreF3) Candidate Vaccine in Older Adults: Phase 1/2 Randomized Clinical Trial
por: Leroux-Roels, Isabel, et al.
Publicado: (2022)

Hospitalizations for Respiratory Syncytial Virus Among Adults in the United States, 1997–2012
por: Pastula, Susan T., et al.
Publicado: (2017)

Estimation of the Number of Respiratory Syncytial Virus–Associated Hospitalizations in Adults in the European Union
por: Osei-Yeboah, Richard, et al.
Publicado: (2023)

Biophysical and flavonoid-binding studies of the G protein ectodomain of group A human respiratory syncytial virus
por: Machado, Vitor Brassolatti, et al.
Publicado: (2019)

Respiratory Syncytial Virus and Other Respiratory Viral Infections in Older Adults With Moderate to Severe Influenza-like Illness
por: Falsey, Ann R., et al.
Publicado: (2014)

Exploring Mechanisms for Effective Technology-Enhanced Simulation-based Education in Wilderness Medicine: A Systematic Review
por: MacKinnon, Ralph, et al.
Publicado: (2015)

Clinical Burden of Respiratory Syncytial Virus in Hospitalized Children Aged ≤5 Years (INSPIRE Study)
por: Hartmann, Katrin, et al.
Publicado: (2022)

Pediatric Respiratory Syncytial Virus Diagnostic Testing Performance: A Systematic Review and Meta-analysis
por: Onwuchekwa, Chukwuemeka, et al.
Publicado: (2023)

Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion state
por: Rossey, Iebe, et al.
Publicado: (2017)

Cationic-nanogel nasal vaccine containing the ectodomain of RSV-small hydrophobic protein induces protective immunity in rodents
por: Umemoto, Shingo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0qunc5vugglmpbdsbshph55m24